|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Bioteque Corp. (邦特生物科技)
Main Activities: Professional, Scientific, and Technical Services
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Bioteque Corp. (邦特生物科技) Headquarters 5/F-6, 23, Chang-An E. Rd., Sec.1, Taipei, Taiwan; New Taipei City; New Taipei City |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational ISIN CODE : TW0004107008 Financial Auditors: KPMG Peat Marwick (2013) Incorporation Date: November 13, 1991 Total Employees: 375 Tel: 886-2-25710269 |
|
Company Description |
| Bioteque Corp. was founded on November 13, 1991 and received ISO9001 quality assurance system certification in September 1998. The company made up public offering in October 1999 and was listed in OTC in October 2001. In March 2002 its stocks were officially traded in OTC. Bioteque is engaged in manufacture and distribution of medical products. The company provides thermoplastic urethane (TPU) tubes, hermodialysis blood line sets, medical soft bags, urine bags, puncture needles, surgical drainage | ||
|
||
Company Analysis |
| According to the Individual - Audited financial statement for the first three cumulated quarters of 2012, total net operating revenues increased with 11.97%, from TWD 557.62 millions to TWD 624.39 millions. Operating result increased from TWD 91.65 millions to TWD 139.83 millions which means 52.57% change. The results of the period increased 49.68% reaching TWD 115.43 millions at the end of the period against TWD 77.12 millions last year. Return on equity (Net income/Total equity) went from 6.46% to 9.38%, the Return On Asset (Net income / Total Asset) went from 4.88% to 7.28% and the Net Profit Margin (Net Income/Net Sales) went from 13.83% to 18.49% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 28.80% compared to 32.41% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 3.74 to 3.31 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2012 Q3C (non-cons) |
2012 Q2C (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| TW Listed Company Financials | TW Listed Company Financials | |
| ||
| Unit | Millions | Millions |
| ||
Balance Sheet
| ||
Total Assets |
1,585 |
1,660 |
| ||
Current Assets |
614 |
678 |
| ||
Total Liabilities |
354 |
468 |
| ||
Shareholders Equity |
1,231 |
1,191 |
| ||
Current Liabilities |
185 |
290 |
| ||
| * All the accounts are in TWD. | ||
Income Statement
| ||
Total Operating Revenue |
624 |
402 |
| ||
Operational Profit (Loss) |
139 |
88 |
| ||
Net Profit (Loss) |
115 |
71 |
| ||
| * All the accounts are in TWD. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
7.28% |
4.28% |
| ||
Annualised Return on Assets (ROA) |
9.71% |
8.56% |
| ||
Return on Equity (ROE) |
9.38% |
5.96% |
| ||
Annualised Return on Equity (ROE) |
12.51% |
11.92% |
| ||
Return on Sales (ROS) |
18.49% |
17.66% |
| ||
Return on Capital |
8.47% |
5.34% |
| ||
Gross Profit Margin |
34.6% |
34.28% |
| ||
Operating Profit Margin |
18.98% |
17.9% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
9.74x |
8.63x |
| ||
Inventory Turnover |
3.39x |
2.33x |
| ||
Current asset turnover |
1.02x |
0.59x |
| ||
Fixed-asset turnover |
0.89x |
0.56x |
| ||
Asset Turnover |
0.39x |
0.24x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
139 |
88 |
| ||
EBITDA |
188 |
120 |
| ||
Enterprise value |
2,888 |
2,820 |
| ||
Enterprise Value / EBITDA |
15.32 |
23.38 |
| ||
Bookvalue (BV) |
1,231 |
1,191 |
| ||
Net Cash |
-297 |
-402 |
| Liquidity Ratios | ||
| ||
Current Ratio |
331.01% |
233.37% |
| ||
Quick ratio |
266.08% |
194.43% |
| ||
Doom's day ratio |
30.59% |
22.98% |
| ||
Cash Flow to Debt |
43.01% |
19.89% |
| Leverage Ratios | ||
| ||
Leverage ratio |
128.8% |
139.34% |
| ||
Interest Coverage Ratio |
6,027.16% |
5,367.27% |
| ||
Debt to equity |
28.8% |
39.34% |
| ||
Debt to total assets |
22.36% |
28.24% |
| ||
Long Term Debt to Capital |
9.6% |
10.34% |
| ||
Debt / Enterprise Value |
12.27% |
16.62% |
| Market ratios | ||
| ||
Market Cap / Net cash |
-8.70 |
-6.02 |
| Trend Ratios | ||
| ||
Revenue Trend |
111.97% |
109.42% |
| ||
Net Income Trend |
149.68% |
126.09% |
| ||
Operating Income Trend |
155.93% |
154.73% |
| ||
 |